期刊文献+

自然周期冻融胚胎移植内膜准备中使用不同药物诱发排卵对妊娠结局的影响 被引量:2

Pregnancy Outcomes of Different Hormonal Induced Cycles in Women with Frozen-thawed Embryo Transfer
下载PDF
导出
摘要 目的:比较采用自然周期冻融胚胎移植内膜准备过程中自然排卵与人绒毛膜促性腺激素(h CG)诱发排卵及促性腺激素释放激素激动剂(Gn RHa)诱发排卵的不同临床结局。方法:回顾性分析湖南省郴州市第一人民医院生殖医学中心2011年10月—2013年10月采用自然周期准备子宫内膜的273例冻融胚胎移植周期。根据是否使用诱发排卵药物及药物的种类分为3组:A组为自然排卵组(n=181);B组为h CG诱发排卵组(n=47);C组为Gn RHa诱发排卵组(n=45)。比较3组患者的临床资料和妊娠结局。结果:13组年龄、移植日子宫内膜厚度、移植胚胎数、移植优胚率等比较差异无统计学意义(P>0.05)。2A组临床妊娠率(56.4%)高于C组(33.3%,P<0.01),而A组临床妊娠率与B组比较差异无统计学意义(P>0.016 7)。结论:在自然周期冻融胚胎移植的内膜准备过程中,使用h CG诱发排卵对妊娠结局无不良影响,而使用Gn RHa诱发排卵则可能影响其临床结局。 Objective: To compare the pregnancy outcomes of spontaneous natural cycle versus human chorionic gonadotropin(h CG) and gonadotropic releasing hormone agonist(Gn RHa) induced cycle in those women with frozen-thawed embryo transfer. Methods:The 273 natural cycles of the frozen-thawed embryo transfer were retrospectively analyzed in our reproductive center from October,2011 to October,2013. Those cycles were divided into three groups according to ovulation inducing methods:group A,spontaneous ovulation(n=181);group B,triggering with h CG(n=47);group C,triggering with Gn RHa(n=45). The pregnancy outcome and other clinical parameters were compared among three groups. Results: 1 There were not significantly differences in age, endometrial thickness on the day of transfer, embryonic number of transfer and the rate of high-quality embryo among three groups(P 〉0.05). 2 The clinical pregnancy rate in group A(56.4%) was significantly higher than that in group C(33.3%,P〈0.01),while there was not significantly difference in this rate between group A and group B(P〉0.016 7). Conclusions:The adverse effect of h CG induced ovulation on the pregnancy outcome was not significant in the frozen-thawed embryo transfer, while Gn RHa induced ovulation may affect the pregnancy outcome of the frozen-thawed embryo transfer.
出处 《国际生殖健康/计划生育杂志》 CAS 2015年第2期98-100,共3页 Journal of International Reproductive Health/Family Planning
关键词 胚胎移植 受精 体外 排卵诱导 妊娠结局 Embryo transfer Fertilization in vitro Ovulation induction Pregnancy outcome
  • 相关文献

参考文献10

  • 1徐明彩,张亦文.GnRH-a替代HCG诱发排卵的研究现状[J].中国优生与遗传杂志,2009,17(7):132-134. 被引量:7
  • 2莫美兰,张宏展,王竹然,曾勇,王丽娟,彭月婷,徐士儒,胡晓东.人绒毛膜促性腺激素诱导排卵与自然排卵在自然周期冻融胚胎移植中妊娠结局的比较[J].生殖医学杂志,2013,22(7):477-480. 被引量:8
  • 3Fatemi HM, Kyrou D, Bourgain C,et al. Cryopreserved -thawed human embryo transfer:spontaneous natural cycle is superior to human chorionic gonadotropin induced natural cycle [J]. Fertil Steril, 2010,94(6) : 2054-2058.
  • 4Chang EM,Han JE,Kim YS,et al. Use of the natural cycle and vitrification thawed blastocyst transfer results in better in-vitro fertilization outcomes[J]. J Assist Reprod Genet, 2011,28 (4) : 369- 374.
  • 5Weissman A, Horowitz E, Ravhon A, et al. Spontaneous ovulation versus HCG triggering for timing natural-cycle frozen-thawed embryo transfer:a randomized study [J]. Reprod Biomed Online, 2011,23 (4) : 484-489.
  • 6Itskovitz J,Boldes R, Levron J,et al. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist[J]. Fertil Steril, 1991,56(2) : 213-220.
  • 7Hoff JD,Quigley ME,Yen SS. Hormonal dynamics at midcycle:a reevaluation[J]. Clin Endocrinol Metab, 1983,57 : 792-796.
  • 8Humaidan P,Papanikolaou EG,Kyrou D,et al. The luteal phase after GnRH-agonist triggering of ovulation:present and future perspectives[J]. Reprod Biomed Online, 2012,24 (2) : 134-141.
  • 9Kashyap S,Parker K,Cedars MI,et al. Ovarian hyperstimulation syndrome prevention strategies:reducing the human chorionic gonadotropin trigger dose [J]. Semin Reprod Med. 2010,28 (6): 475-485.
  • 10Humaidan P,Kol S,Papanikolaou EG,et al. GnRH agonist for triggering of final ooeyte maturation: time for a change of practice? [J]. Hum Reprod Update,2011,17(4) :510-524.

二级参考文献27

  • 1张四友,郑敏.促性腺激素释放激素激动剂替代绒毛膜促性腺激素诱导排卵预防卵巢过度剌激综合征的初步观察[J].生殖医学杂志,2004,13(5):273-275. 被引量:12
  • 2孙亦婷,赵雅云,周黎明.短效达必佳对HMG促排卵周期中卵巢过度刺激综合征高危患者的应用价值[J].现代实用医学,2006,18(9):642-643. 被引量:7
  • 3帅祖兵,邱文英,徐佳丽,李晶晶.曲普瑞林触发排卵的临床研究[J].中国新药杂志,2006,15(20):1774-1776. 被引量:8
  • 4Shoham Z,Sehaeter M,Loumaye E,et al.The luteinizing hormone surge-the final stage in ovulation induction:modem aspects of ovulation triggering[J].Fertil Steril,1995,64(2):237 -251.
  • 5Loumaye E,et al.In Filicori M,Flamigni C eds.Treatment with GnRH Analogs[M].Controversies and Perspectives Parthenon Publishing Group.New York:1996:201-209.
  • 6Kol S,et al.Hum Reprod,1996,11(6):1143 -1144.
  • 7Seminara SB,Beranova M,Oliveira LM,et al.Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and prngnsncy in a patient with GnRH receptor mutations[J].J Clin Endoerinol Metab,200o,85(2):556 -562.
  • 8Romen A,et al.J Assist Reprod Genet,1997,14(9):518 -524.
  • 9Lewit N,KOL S,Manor D,et al.Comparison of gonadotrophiu -releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome:a case -control study[J].Hum Reprod,1996,11(7):1399-1402.
  • 10Blumenfeld Z,Lang N,Amit A,et al.Native gonadotrepin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction[J].Fertil Steril,1994,62 (3):456-460.

共引文献13

同被引文献21

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部